Furthermore, the Cancer Genome Atlas (TCGA) data analysis also reveals a higher relative abundance of CD4+ and CD8+ T cells in female CRC patients, indicating a potential immunological advantage 13. This evidence concerns the gene CD8A and colorectal carcinoma.